Neuroprotection ? rationale for pharmacological modulation of Na+-channels
- 1 March 1998
- journal article
- review article
- Published by Springer Nature in Amino Acids
- Vol. 14 (1) , 151-158
- https://doi.org/10.1007/bf01345256
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Neuroprotective Properties of the Novel Antiepileptic Lamotrigine in a Gerbil Model of Global Cerebral IschemiaStroke, 1995
- Cerebroprotective Effect of Lamotrigine After Focal Ischemia in RatsStroke, 1995
- Hypoxic-ischemic injury in the neonatal rat brain: effects of pre-and post-treatment with the glutamate release inhibitor BW1003C87Developmental Brain Research, 1994
- Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia.Stroke, 1994
- BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.Stroke, 1993
- An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channelsPublished by Elsevier ,1992
- Synaptosomal Respiration: A Potent Indicator of Veratridine-Induced Na InfluxPharmacology, 1991
- Preloading In Vivo: A Rapid and Reliable Method for Measuring γ‐Aminobutyric Acid and Glutamate Fluxes by MicrodialysisJournal of Neurochemistry, 1990
- Lidocaine accelerates neuroelectrical recovery after incomplete global ischemia in rabbits.Stroke, 1990
- Cerebral cation shifts in hypoxic-ischemic brain damage are prevented by the sodium channel blocker tetrodotoxinExperimental Neurology, 1988